DPI Acquisition Boosts Inhaled Powder Manufacturing

Establishing a global center of excellence for spray dried dispersion for dry powder inhaler (DPI) capsule manufacturing, and expanding its existing U.S.-based commercial-scale capabilities in MDIs and nasal inhalation.

Catalent Partnering with Multiple Customers on COVID-Related Vaccines and Therapies

Including Johnson & Johnson, AstraZeneca, Moderna and Humanigen
Catalent is the #1 partner in helping pharmaceutical, biotech and consumer health innovators develop, deliver and supply superior products that improve people’s lives.

DPI Acquisition Boosts Inhaled Powder Manufacturing

Establishing a global center of excellence for spray dried dispersion for dry powder inhaler (DPI) capsule manufacturing, and expanding its existing U.S.-based commercial-scale capabilities in MDIs and nasal inhalation.

Catalent Partnering with Multiple Customers on COVID-Related Vaccines and Therapies

Including Johnson & Johnson, AstraZeneca, Moderna and Humanigen
Catalent is the #1 partner in helping pharmaceutical, biotech and consumer health innovators develop, deliver and supply superior products that improve people’s lives.

How can we work together